570:HKEXChina Traditional Chinese Medicine Holdings Co. Ltd. Analysis

Muhibbah Engineering (M) Bhd. trades around MYR 0.53, well below its DCF fair value of roughly MYR 1.35, implying a potential upside of over 50%. The stock’s PE of 4.8 is dramatically lower than the industry average of 29.7, and the price‑to‑book ratio sits at just 0.27, signaling deep value compression. However, revenue has contracted by 27% and free cash flow is negative, raising concerns about earnings momentum and cash generation. The dividend yield of 5.66% is attractive, yet the payout ratio is modest at 28% and the negative cash flow suggests sustainability risk. Technicals are mixed: the 20‑day SMA (0.542) sits just above the current price, the RSI is neutral at 48, and the MACD histogram is bearish, indicating limited short‑term upside. Liquidity appears adequate with stable volume, but the stock’s beta of 0.38 points to low market‑wide volatility, while its 30‑day price volatility of 30% signals higher idiosyncratic risk.
Given the strong valuation gap, high dividend yield, and defensive sector positioning, the stock could be a compelling value play if cash flow improves. Nonetheless, the ongoing revenue decline, negative free cash flow, and exposure to cyclical engineering contracts temper enthusiasm, suggesting a cautious approach until operational trends reverse.